Uri Weinberg - 03 Mar 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Science Officer
Signature: By: /s/ Steven Robbins, Attorney in Fact for Uri Weinberg
Issuer symbol: NVCR
Transactions as of: 03 Mar 2022
Net transactions value: +$2,851,516
Form type: 4
Filing time: 07 Mar 2022, 17:25:21 UTC
Previous filing: 12 Jan 2022
Next filing: 07 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award	$0	+17,371	+55%	$0.000000	49,186	03 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Options to Buy Ordinary Shares	Award	$2,451,709	+30,422		$80.59	30,422	03 Mar 2022	Ordinary Shares	30,422	$80.59	Direct	F2
transaction	NVCR	Options to Buy Ordinary Shares	Award	$399,807	+4,961		$80.59	4,961	03 Mar 2022	Ordinary Shares	4,961	$80.59	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units that are scheduled to vest on March 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.
F2	Options to buy 30,422 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
F3	Options to buy 4,961 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.